Smith, Moore & Co. Eli Lilly & CO Transaction History

Smith, Moore & Co.

$1.03 Billion
Q3 2024

A detailed history of Smith, Moore & Co. transactions in Eli Lilly & CO stock. As of the latest transaction made, Smith, Moore & Co. holds 8,287 shares of LLY stock, worth $6.24 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares

8,287

Previous 8,328 0.49%

Holding current value

$6.24 Million

Previous $7.54 Million 2.64%

% of portfolio

0.71%

Previous 0.78%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$772.14 - $960.02 $31,657 - $39,360	-41 Reduced 0.49%	8,287 $7.34 Million
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $542,202 - $679,961	-748 Reduced 8.24%	8,328 $7.54 Million
Q1 2024 May 10, 2024	BUY	$592.2 - $792.28 $614,111 - $821,594	1,037 Added 12.9%	9,076 $7.06 Million
Q4 2023 Feb 13, 2024	BUY	$525.19 - $619.13 $165,434 - $195,025	315 Added 4.08%	8,039 $4.69 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $21,735 - $29,964	50 Added 0.65%	7,724 $4.15 Million
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $474,551 - $634,529	1,353 Added 21.4%	7,674 $3.6 Million
Q1 2023 May 12, 2023	BUY	$310.63 - $364.82 $288,264 - $338,552	928 Added 17.21%	6,321 $2.17 Million
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $18,649 - $21,730	58 Added 1.09%	5,393 $1.97 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $66,115 - $75,345	-223 Reduced 4.01%	5,335 $1.73 Million
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $223,262 - $262,143	-801 Reduced 12.6%	5,558 $1.8 Million
Q1 2022 May 12, 2022	BUY	$234.69 - $291.66 $11,969 - $14,874	51 Added 0.81%	6,359 $1.82 Million
Q4 2021 Feb 08, 2022	BUY	$224.85 - $279.04 $76,673 - $95,152	341 Added 5.71%	6,308 $1.74 Million
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $50,524 - $62,177	228 Added 3.97%	5,967 $1.38 Million
Q2 2021 Aug 10, 2021	SELL	$180.55 - $233.54 $3,611 - $4,670	-20 Reduced 0.35%	5,739 $1.32 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $31,220 - $40,416	190 Added 3.41%	5,759 $1.08 Million
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $78,406 - $103,750	-601 Reduced 9.74%	5,569 $940,000
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $78,812 - $91,161	539 Added 9.57%	6,170 $913,000
Q2 2020 Aug 10, 2020	BUY	$136.42 - $164.18 $119,640 - $143,985	877 Added 18.45%	5,631 $925,000
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $19,048 - $23,576	160 Added 3.48%	4,754 $659,000
Q4 2019 Feb 07, 2020	BUY	$106.92 - $132.43 $129,052 - $159,843	1,207 Added 35.64%	4,594 $604,000
Q3 2019 Nov 07, 2019	SELL	$106.79 - $116.16 $2,349 - $2,555	-22 Reduced 0.65%	3,387 $379,000
Q2 2019 Aug 15, 2019	BUY	$110.79 - $129.32 $102,259 - $119,362	923 Added 37.13%	3,409 $378,000
Q1 2019 May 07, 2019	SELL	$111.31 - $131.02 $6,122 - $7,206	-55 Reduced 2.16%	2,486 $323,000
Q4 2018 Feb 15, 2019	SELL	$105.9 - $118.64 $211 - $237	-2 Reduced 0.08%	2,541 $294,000
Q3 2018 Nov 15, 2018	BUY	$85.86 - $107.31 $8,671 - $10,838	101 Added 4.14%	2,543 $273,000
Q2 2018 Aug 14, 2018	BUY	$75.7 - $86.88 $184,859 - $212,160	2,442 New	2,442 $208,000
Q1 2018 May 14, 2018	SELL	$74.21 - $87.6 $177,510 - $209,539	-2,392 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$81.94 - $87.89 $81 - $87	1 Added 0.04%	2,392 $202,000
Q3 2017 Nov 02, 2017	BUY	$77.07 - $85.54 $184,274 - $204,526	2,391	2,391 $205,000

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $716B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Smith, Moore & Co., based on Form 13F filings with the SEC.

News

Stay updated on Smith, Moore & Co. with notifications on news.

Account